Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia.

about

Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia.

Item

http://www.wikidata.org/entity/Q47696149

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tolterodine treatment of women ...... d daytime dosing for nocturia.

@en

Tolterodine treatment of women ...... d daytime dosing for nocturia.

@nl

type

Item

label

Tolterodine treatment of women ...... d daytime dosing for nocturia.

@en

Tolterodine treatment of women ...... d daytime dosing for nocturia.

@nl

prefLabel

Tolterodine treatment of women ...... d daytime dosing for nocturia.

@en

Tolterodine treatment of women ...... d daytime dosing for nocturia.

@nl

P1476

Tolterodine treatment of women ...... nd daytime dosing for nocturia

@en

P2093

Ko-Hsin Tsai

http://www.w3.org/2001/XMLSchema#string

Sheng-Mou Hsiao

http://www.w3.org/2001/XMLSchema#string

P2860

The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society

Muscarinic receptor antagonists for overactive bladder.

The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Impact of Dry Mouth on Fluid Intake and Overactive Bladder Symptoms in Women taking Fesoterodine.

Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women.

An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Current pharmacotherapy of nocturia.

Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine.

Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial.

Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

P304

1719-1725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOG.13438

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ho-Hsiung Lin

P577

2017-07-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28714288

http://www.w3.org/2001/XMLSchema#string